Press Inquiries

T1International Statement on HR 6833 and the Affordable Insulin Now Act Vote

31 Mar 2022, 8 p.m. in #insulin4all USA, News & Statements, Press Inquiries by T1International

On Thursday, March 31st, the US House of Representatives voted to pass a $35 insulin copay cap. The bill now heads to the Senate. While a $35 copay cap on insulin would impact many people, T1International is calling on the Senate to pass a true price cap on insulin for everyone, especially those without insurance. Read more